Ironwood Pharmaceuticals (IRWD) Return on Capital Employed Growth (1y) (2012 - 2026)
Ironwood Pharmaceuticals (IRWD) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn | 1,195.00 |
| 10 | Ironwood Pharmaceuticals | 638.28 Mn | 417.81 Mn | - | 9,335.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,335.00 |
| Dec 31, 2025 | 3,575.00 |
| Sep 30, 2025 | 6,809.00 |
| Jun 30, 2025 | 4,095.00 |
| Mar 31, 2025 | 50,932.00 |
| Dec 31, 2024 | 45,500.00 |
| Sep 30, 2024 | 35,204.00 |
| Jun 30, 2024 | 18,499.00 |
| Mar 31, 2024 | -51,398.00 |
| Dec 31, 2023 | -45,085.00 |
| Sep 30, 2023 | -34,745.00 |
| Jun 30, 2023 | -17,781.00 |
| Mar 31, 2023 | -267.00 |
| Dec 31, 2022 | -71.00 |
| Sep 30, 2022 | -97.00 |
| Jun 30, 2022 | -764.00 |
| Mar 31, 2022 | -596.00 |
| Dec 31, 2021 | -429.00 |
| Sep 30, 2021 | -715.00 |
| Jun 30, 2021 | -963.00 |